The transaction accelerates the expiration of biosimilars non-compete restrictions, the company said.

The U.S. health regulator on Friday approved Innoviva's oral antibiotic to treat gonorrhea, a common sexually transmitted infection, offering patients an alternative to an injectable drug that was the ...

Among adults with hereditary angioedema, a one-time infusion of lonvoguran ziclumeran immediately lowered the average monthly ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

IV iron administration has historically been a “controversial issue” for treatment of iron deficiency anemia during acute infections, but data presented at ASH Annual Meeting and Exposition detailed ...

Treatment with intravenous (IV) iron significantly improved survival and increased hemoglobin levels in patients with ...

Inebilizumab-cdon is approved for anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody–positive generalized myasthenia gravis, based on MINT trial results. Inebilizumab gains ...

“‘Nobody was gonna give it a shot because it was just so overwhelming that I wasn’t there in Maiden anymore." When Bruce Dickinson walked away from Iron Maiden in 1993, a lot of metalheads treated it ...

As Hearts of Iron 4 storms through its tenth year since launch, new DLC No Compromise, No Surrender has finally arrived to deliver a comprehensive upgrade to the conflict in Asia. One of the best WW2 ...

Got nothing better to do this weekend than try your hand at leading a nation to victory in World War II in one of the best strategy games ever made? On the back of a new DLC entry for the nearly ...

Early panretinal photocoagulation plus anti-VEGF for macular edema secondary to retinal vein occlusion offers no benefit over anti-VEGF alone.

Mould new paths in history for Japan, China and the Philippines in No Compromise, No Surrender, an Expansion for Hearts of Iron IV. Seize a greater depth of control over factions, forge new military ...